Skip to main content

AstraZeneca buys Bristol-Myers Squibb's stake in diabetes alliance for $4.1B

AstraZeneca reached an agreement Thursday to acquire Bristol-Myers Squibb's global diabetes business for up to $4...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.